期刊文献+

换脸术几个问题的理性思考 被引量:6

Discussion about Facial Allotransplantation
下载PDF
导出
摘要 换脸术是目前国内外争论的一个焦点,是异体器官移植领域内新的突破,为严重毁容患者带来了重新获得美容的希望。但是目前还有很多问题需要进一步。在远期疗效尚未肯定的情况下,作为医务工作者,我们需要加强自身修养和伦理道德教育,做出正确的决定,并不断进行相关研究,最终广泛应用于临床,造福于人类。 Facial allotransplantation, a new breakthrough in allotransplantation, has been drastically debated in the whole world, which give a new hope for traumatic deformities of the head and neck region. But we has still many problem which need further- more overcome. At presently, the prospective efficacy hasn't affirmed, so it is necessary to improve the level of surgeon, including professional and ethical education, so that they can make a correct decision and study correlative items. We believe that the new technology will be widely applied and take advantage to the human.
出处 《医学与哲学(B)》 2006年第5期74-75,共2页 Medicine & Philosophy(B)
关键词 异体移植 颜面缺损 伦理 换脸术 aUotransplantation, facial defect, ethic
  • 相关文献

参考文献4

二级参考文献61

  • 1Dubemard JM,Oven E,Herzberg G,et al.Human hand allograft:report on 6months[J]. Lancet, 1999,353(3):1315.
  • 2Levi DM,Tzakis AG,Kato T, et al.Transplantation of the abdominal wall[J]. Lancet, 2003, 361(9376): 2173-2176.
  • 3Djamali A,Premasathian N,Pirsch JD. Outcomes in kidney transplantation. Semin Nephrol[J]. 2003, 23(3): 306-316.
  • 4Shimizu H, Takahashi M,Takeda S,et al. Mycophenolate mofetil prevents transplant arteriosclerosis by direct inhibition of vascular smooth muscle cell proliferation. Transplantation [J]. 2004,77(11): 1661-1667.
  • 5Kunzendorf U, Ziegler E, Kabelitz D. FTY720--the first compound of a new promising class of immunosuppressive drugs[J].Nephrol Dial Transplant, 2004, 19(7):1677-1681.
  • 6Zhang L,Zhu T,Sun EW, et al. Pretreatment with FTY720 alone induced long-term survival of mouse heart allograft[J].Transplant Proc,2003,35(1):567-568.
  • 7Tedesco-Silva H, Mourad G, Kahan BD ,et al. FTY720, A novel immunomodulator: efficacy and safety results from the first phase 2Astudy in de novo renal transplantation[J]. Transplantation, 2004, 77(12): 1826-1833.
  • 8Langer HE, Missler-Karger B.Kineret: efficacy and safety in daily clinical practice: an interim analysis of the Kineret response assessment initiative (kreative) protocol[J]. Int J Clin Pharmacol Res, 2003,23(4):119-128.
  • 9Ziemer M, Gruhn B, Thiele JJ,et al. Treatment of extensive chronic cutaneous graft-versus-host disease in an infant with topical pimecrolimus [J].J am Acad Dermatol,2004,50 (6):946-948.
  • 10Holmes M, Chilcott J, Walters S, Whitby S,et al. Economic evaluation of everolimus versus mycophenolate mofetil in combination with cyclosporine and prednisolone in de novo renal transplant recipients[J]. Transpl Int,2004,17(4):182-187.

共引文献8

同被引文献69

引证文献6

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部